Valerio Therapeutics (FRA:C4X) Short-Term Capital Lease Obligation : €0.31 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Valerio Therapeutics Short-Term Capital Lease Obligation?

Valerio Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.31 Mil.

Valerio Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 (€0.33 Mil) to Dec. 2023 (€0.33 Mil) but then declined from Dec. 2023 (€0.33 Mil) to Jun. 2024 (€0.31 Mil).

Valerio Therapeutics's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€0.47 Mil) to Dec. 2022 (€0.34 Mil) and declined from Dec. 2022 (€0.34 Mil) to Dec. 2023 (€0.33 Mil).

Valerio Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Valerio Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Short-Term Capital Lease Obligation Chart

Valerio Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.48

0.47

0.34

0.33

Valerio Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.47	0.34	0.33	0.33	0.31

Valerio Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Valerio Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Valerio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (FRA:C4X) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

0NWK:UK ALVIO:France C4X:Germany

Address

49 Boulevard du General, Martial Valin, Paris, FRA, 75015

Website

https://www.valeriotx.com

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics Headlines

No Headlines